Alzheimer's disease & dementia

New memory drug moves into Phase 1 clinical study

An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the NIH Blueprint Neurotherapeutics Network, ...

Medical research

Device delivers drugs to brain via remote control

A team of researchers has developed a wireless device the width of a human hair that can be implanted in the brain and activated by remote control to deliver drugs.

Neuroscience

Observing brain network dynamics to diagnose Alzheimer's disease

Various types of information can be ascertained by the way blood flows through the brain. When a region of the brain has been activated, blood flow increases and oxygenation rises. By observing variations in blood flow with ...

page 30 from 40